Stress urinary incontinence (SUI)is a condition that associated with social impact and a reduced quality of life for women of each age group, current treatment methods do not yield satisfactory results. The middle urethral contained rhabdosphincter is critical for maintaining continence through the pathogenesis of stress incontinence exploration. In recent years, research of autologous stem cell-based therapy research suggests a new favorable paradigm in treatment for female SUI. The application of stem cell injectable therapy in the treatment of SUI is reviewed in this article.%压力性尿失禁在各年龄段妇女普遍存在,严重影响女性生活质量及社会形象,现行的治疗手段效果不理想.对压力性尿失禁发病机制的探索,已认识到中段尿道及尿道外括约肌是尿控关键.近年,自体干细胞移植作为新的治疗手段,对女性压力性尿失禁的治疗获得可喜成果.综述干细胞治疗女性压力性尿失禁的近况.
展开▼
